Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3807279
Title:
SELS PHARMACEUTIQUEMENT ACCEPTABLES DE SÉPIAPTÉRINE AVEC UNE STABILITÉ AMÉLIORÉE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
198111270
WO application number:
US2019034505
Type:
European patent granted for BE
Status:
Open
Publication number:
3807279
WO publication number:
WO2019232120
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
30/05/2019
Grant date:
31/12/2025
EP publication date:
21/04/2021
WO publication date:
05/12/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
31/12/2025
EP B1 publication date:
31/12/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/05/2039
Applicant
Name:
PTC Therapeutics MP, Inc.
Legal Form:
From:
31/12/2025
Address:
500 Warren Corporate Center Drive, Warren, NJ 07059, United States (US)
To:
Inventor
1
Name:
LEVY, Daniel, E.
Legal Form:
Address:
San Mateo, CA 94402, United States (US)
2
Name:
SMITH, Neil
Legal Form:
Address:
Wellesley, MA 02481, United States (US)
3
Name:
REIS, Jonathan
Legal Form:
Address:
Wellesley, MA 02481, United States (US)
4
Name:
YOSHINO, Hiroshi
Legal Form:
Address:
Narashino-shi, Japan (JP)
5
Name:
KOMODA, Taichi
Legal Form:
Address:
Narashino-shi, Japan (JP)
6
Name:
SHIRO, Yuichi
Legal Form:
Address:
Narashino-shi, Japan (JP)
7
Name:
MURATA, Shunichi
Legal Form:
Address:
Narashino-shi, Japan (JP)
8
Name:
MATSUMOTO, Takayoshi
Legal Form:
Address:
Narashino-shi, Japan (JP)
9
Name:
KISHIMOTO, Kaito
Legal Form:
Address:
Narashino-shi, Japan (JP)
Priority
1
Priority patent number:
201962822336 P
Priority date:
22/03/2019
Priority country:
United States (US)
2
Priority patent number:
201862726612 P
Priority date:
04/09/2018
Priority country:
United States (US)
3
Priority patent number:
201862678025 P
Priority date:
30/05/2018
Priority country:
United States (US)
4
Priority patent number:
201937661
Priority date:
28/05/2019
Priority country:
Cooperation Council for the States of the Gulf (GC)